Oncoloxía médica
Servicio
University of Freiburg
Friburgo de Brisgovia, AlemaniaPublicacións en colaboración con investigadores/as de University of Freiburg (2)
2013
-
Bevacizumab plus chemotherapy continued beyond first progression in patients withmetastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
Annals of Oncology, Vol. 24, Núm. 9, pp. 2342-2349